Filing Flows

Filing Flows › Opko Health (OPK) › Q2 2025

Opko Health (OPK) Q2 2025 earnings results (second quarter 2025)

10-Q filed Jul 31, 2025

Opko Health (OPK) reported revenue of $157M for the second quarter 2025 (Q2 2025), -14% from a year earlier and +5% from the quarter before. Operating margin was -38.3%, net loss $148M (94.7% of revenue).

Revenue$157M
Year over year-14%
Quarter over quarter+5%
Operating margin-38.3%
Net earnings−$148M

Opko Health, Q2 2025: revenue $157M (-14% year over year), operating margin -38.3%, net loss $148M, operating cash flow −$83.4M. The chart follows the revenue to costs, profit and cash.

Q2 2025AmountQ/QY/Y
Revenue$157M+5%-14%
Operating profit−$60.0M——
Net earnings−$148M——
Operating cash flow−$83.4M——

What changed

Revenue was $156.8M in Q2 2025, down 14% year over year and up 5% from the previous quarter. Service was the largest line at 64% of revenue. Service lost $28.3M year over year (down 22%), 111% of the total change.

Gross margin was 31.5%, up 3.2 points from a year earlier. Operating costs exceeded revenue by $60.0M, an operating margin of -38.3%. Operating expenses fell 3% while revenue fell 14%. The fastest-growing cost line was Research & development (+26%). The quarter ended with a net loss of $148.4M, wider than the previous quarter's $67.6M loss. Net interest and other expense of $102.5M was the main reason.

Operating cash flow was −$83.4M. Non-cash charges added back $23.0M of depreciation and amortization and $2.2M of share-based compensation. Working capital and other items added $39.8M. Capital expenditures of $3.3M exceeded it, leaving free cash flow of −$86.7M.

Questions

What was Opko Health's revenue in the second quarter 2025?

Opko Health (OPK) reported revenue of $157M for the second quarter 2025 (Q2 2025), -14% from a year earlier and +5% from the quarter before.

Was Opko Health profitable in the second quarter 2025?

Operating loss was $60.0M (-38.3% of revenue) and net loss $148M.

Open the interactive Sankey →

Source: Opko Health 10-Q on SEC EDGAR.